Regeneron · 5 hours ago
Executive Director, Strategic Customer Engagement, Neurology CBU
Regeneron is a leading biotechnology company focused on providing innovative solutions in healthcare. They are seeking an Executive Director for Strategic Customer Engagement within the Neurology Commercial Business Unit, responsible for leading field teams, optimizing business performance, and driving the launch of new neurology brands.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Provide strategic oversight and enhance launch and execution excellence for our newly launching brand for Myasthenia Gravis in the US
Create a strategic coordinated approach for our field teams calling on customers
The incumbent will be responsible for optimizing business performance for the Neurology Sales Specialists
Lead the Field teams, motivating and developing the team to deliver upon CBU operational and financial goals and customer expectations
Provide strategic leadership and cross-functional direction to successfully drive the launch for Regeneron’s neurology brands
Navigate all relevant cross functional teams to successfully deliver Regeneron’s neurology portfolio to patients in need
Foster a customer/patient driven Regeneron culture ensuring patients are first in all business activities
Deliver Field commitments within budget, revenue targets and timelines while ensuring Field team compliance with federal, state and local laws, industry regulations and guidelines
Develop and implement a commercial customer-facing strategy that will enable Regeneron to become a major player serving the Neurology market
Contribute to the development of the Company’s strategic commercial plan to significantly and profitably grow the business
Provide field leadership and direction to the Neurology customer-facing field teams including hiring, motivating, and developing the team to deliver upon customer expectations
Establish credible and trusted relationships with key organizational and business collaborators inside and outside of Regeneron
Develop key relationships with experts in the Neurology therapeutic area
Lead a high quality, high performing field team capable of realizing fully Regeneron’s technology and commercial promise to patients
Ensure Regeneron Executive Leadership is kept aware of significant external events and threats that may affect our business and proactively make recommendations to address them in a timely manner
Ensure Field team compliance with federal, state and local laws, industry regulations and guidelines at all times
Qualification
Required
BS in a life sciences or related field; MBA preferred
Recent launch experience in the Rare Neurology injectable market a strong plus
Minimum of 15 years people and industry leadership experience through progressively increasing leadership positions
Strong leadership skills required including strong record of hiring, developing and retaining personnel while delivering agreed revenue targets
Experience in biologic products and experience in the 'buy and bill' reimbursement area is required
Preferred
Experience in both major pharmaceutical and in biotech companies is preferred with a recent track record of successful product launches in the injectable biologics therapeutic area
Neurology experience is preferred and Myasthenia Gravis or Neurology Rare Disease experience a plus
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Recent News
Pharmaceutical Technology
2026-01-16
2026-01-16
Company data provided by crunchbase